殷紅歌頌的殘缺

Blog By Selice

[生物資訊期末報告]PROMO Search Result For The Interferon Regulatory Factor Family(IRF1-IRF5)

Factors predicted by PROMO in IRF1 sequence:

NAME; MATRIX_WIDTH;
XBP-1 [T00902]; 6
YY1 [T00915]; 4
RXR-alpha [T01345]; 7
ENKTF-1 [T00255]; 8
GR-beta [T01920]; 5
TFII-I [T00824]; 6
STAT4 [T01577]; 6
c-Ets-1 [T00112]; 7
FOXP3 [T04280]; 6
NFI/CTF [T00094]; 8
GR [T05076]; 7
TFIID [T00820]; 7
GR-alpha [T00337]; 5
Elk-1 [T00250]; 9
PR B [T00696]; 7
PR A [T01661]; 7
C/EBPbeta [T00581]; 4
AP-2alphaA [T00035]; 6
SRY [T00997]; 9
TCF-4E [T02878]; 7
IRF-1 [T00423]; 9
NF-AT1 [T00550]; 9
c-Myb [T00137]; 8
VDR [T00885]; 9
PXR-1:RXR-alpha [T05671]; 8
GATA-1 [T00306]; 6
c-Ets-2 [T00113]; 9
T3R-beta1 [T00851]; 9
AP-1 [T00029]; 9
c-Jun [T00133]; 7
Pax-5 [T00070]; 7
p53 [T00671]; 7
ER-alpha [T00261]; 5
ATF3 [T01313]; 8
PEA3 [T00685]; 9
MAZ [T00490]; 13
NF-1 [T00539]; 8
C/EBPalpha [T00105]; 7
EBF [T05427]; 11
NF-Y [T00150]; 8
USF2 [T00878]; 10
RAR-alpha1 [T00719]; 13
ETF [T00270]; 11
NF-kappaB [T00590]; 12
RelA [T00594]; 11
AR [T00040]; 9
GATA-2 [T00308]; 9
Ik-1 [T02702]; 13
NF-AT2 [T01945]; 10
STAT1beta [T01573]; 10
c-Fos [T00123]; 10
ELF-1 [T01113]; 13
PU.1 [T02068]; 13
LEF-1 [T02905]; 8
PPAR-alpha:RXR-alpha [T05221]; 11
POU2F1 [T00641]; 11

Distribution of the nucleotides over the given chain:

A 26.7%
C 27.1%
G 27.5%
T 18.7%

Factors predicted by PROMO in IRF-2 sequence:

NAME; MATRIX_WIDTH;
XBP-1 [T00902]; 6
IRF-1 [T00423]; 9
GR-alpha [T00337]; 5
NF-AT1 [T00550]; 9
Pax-5 [T00070]; 7
p53 [T00671]; 7
ENKTF-1 [T00255]; 8
FOXP3 [T04280]; 6
TFII-I [T00824]; 6
c-Myb [T00137]; 8
PR B [T00696]; 7
PR A [T01661]; 7
HNF-1A [T00368]; 8
c-Ets-2 [T00113]; 9
TFIID [T00820]; 7
GR-beta [T01920]; 5
YY1 [T00915]; 4
NFI/CTF [T00094]; 8
GR [T05076]; 7
AP-2alphaA [T00035]; 6
STAT4 [T01577]; 6
c-Ets-1 [T00112]; 7
C/EBPbeta [T00581]; 4
C/EBPalpha [T00105]; 7
AP-1 [T00029]; 9
c-Jun [T00133]; 7
HNF-3alpha [T02512]; 8
EBF [T05427]; 11
GATA-2 [T00308]; 9
GATA-1 [T00306]; 6
STAT5A [T04683]; 13
SRY [T00997]; 9
TCF-4E [T02878]; 7
c-Fos [T00123]; 10
IRF-2 [T01491]; 6
ATF3 [T01313]; 8
TBP [T00794]; 10
VDR [T00885]; 9
PXR-1:RXR-alpha [T05671]; 8
T3R-beta1 [T00851]; 9
E2F-1 [T01542]; 8
ER-alpha [T00261]; 5
RXR-alpha [T01345]; 7
Elk-1 [T00250]; 9
ETF [T00270]; 11
RAR-alpha1 [T00719]; 13
PEA3 [T00685]; 9
POU2F2 (Oct-2.1) [T00646]; 11
LEF-1 [T02905]; 8
TCF-4 [T02918]; 10
NF-1 [T00539]; 8
Sp1 [T00759]; 10
E2F [T00221]; 10
NF-Y [T00150]; 8
AR [T00040]; 9
PU.1 [T02068]; 13
PPAR-alpha:RXR-alpha [T05221]; 11
HNF-1C [T01951]; 9
HNF-1B [T01950]; 9
NF-AT2 [T01945]; 10
STAT1beta [T01573]; 10
HOXD9 [T01424]; 10
HOXD10 [T01425]; 10
NF-AT1 [T01948]; 10
Ik-1 [T02702]; 13

Distribution of the nucleotides over the given chain:

A 30.5%
C 25.4%
G 25.2%
T 18.9%

Factors predicted by PROMO in IRF3(transcript variant 1) sequence:

NAME; MATRIX_WIDTH;
RXR-alpha [T01345]; 7
RAR-beta [T00721]; 10
SRY [T00997]; 9
TCF-4E [T02878]; 7
NFI/CTF [T00094]; 8
GR [T05076]; 7
Pax-5 [T00070]; 7
p53 [T00671]; 7
ENKTF-1 [T00255]; 8
FOXP3 [T04280]; 6
c-Myb [T00137]; 8
GR-alpha [T00337]; 5
VDR [T00885]; 9
PXR-1:RXR-alpha [T05671]; 8
PR B [T00696]; 7
PR A [T01661]; 7
E2F-1 [T01542]; 8
AhR:Arnt [T05394]; 10
STAT4 [T01577]; 6
c-Ets-1 [T00112]; 7
Elk-1 [T00250]; 9
PEA3 [T00685]; 9
C/EBPbeta [T00581]; 4
NF-1 [T00539]; 8
XBP-1 [T00902]; 6
GR-beta [T01920]; 5
AP-2alphaA [T00035]; 6
c-Ets-2 [T00113]; 9
NF-AT2 [T01945]; 10
TFII-I [T00824]; 6
STAT1beta [T01573]; 10
HNF-3alpha [T02512]; 8
NF-kappaB [T00590]; 12
HNF-1C [T01951]; 9
ETF [T00270]; 11
Ik-1 [T02702]; 13
RAR-beta:RXR-alpha [T05420]; 12
PPAR-alpha:RXR-alpha [T05221]; 11
TFIID [T00820]; 7
YY1 [T00915]; 4
AP-1 [T00029]; 9
c-Jun [T00133]; 7
AR [T00040]; 9
E2F [T00221]; 10
NF-kappaB1 [T00593]; 11
ER-alpha [T00261]; 5
C/EBPalpha [T00105]; 7
T3R-beta1 [T00851]; 9
c-Fos [T00123]; 10
c-Myc [T00140]; 6
USF1 [T00874]; 10
EBF [T05427]; 11
STAT5A [T04683]; 13
NF-AT1 [T01948]; 10
Egr-3 [T00243]; 13
MAZ [T00490]; 13
IRF-1 [T00423]; 9
NF-AT1 [T00550]; 9
HIF-1 [T01609]; 9
COUP-TF1 [T00149]; 13
GATA-1 [T00306]; 6
NF-Y [T00150]; 8
LEF-1 [T02905]; 8
RelA [T00594]; 11

Distribution of the nucleotides over the given chain:

A 19.9%
C 29.7%
G 32.4%
T 18.0%

Factors predicted by PROMO in IRF4 sequence:

NAME; MATRIX_WIDTH;
XBP-1 [T00902]; 6
FOXP3 [T04280]; 6
PXR-1:RXR-alpha [T05671]; 8
GR-alpha [T00337]; 5
AP-2alphaA [T00035]; 6
E2F-1 [T01542]; 8
ENKTF-1 [T00255]; 8
RXR-alpha [T01345]; 7
STAT4 [T01577]; 6
c-Ets-1 [T00112]; 7
Elk-1 [T00250]; 9
PEA3 [T00685]; 9
AhR:Arnt [T05394]; 10
GCF [T00320]; 9
C/EBPbeta [T00581]; 4
NF-1 [T00539]; 8
c-Ets-2 [T00113]; 9
IRF-1 [T00423]; 9
NF-AT1 [T00550]; 9
TFII-I [T00824]; 6
MAZ [T00490]; 13
USF2 [T00878]; 10
VDR [T00885]; 9
LEF-1 [T02905]; 8
TCF-4 [T02918]; 10
PR B [T00696]; 7
PR A [T01661]; 7
GR-beta [T01920]; 5
c-Myb [T00137]; 8
SRY [T00997]; 9
TCF-4E [T02878]; 7
GR [T05076]; 7
C/EBPalpha [T00105]; 7
NFI/CTF [T00094]; 8
SRF [T00764]; 13
T3R-beta1 [T00851]; 9
AR [T00040]; 9
YY1 [T00915]; 4
Pax-5 [T00070]; 7
p53 [T00671]; 7
Ik-1 [T02702]; 13
RBP-Jkappa [T01616]; 12
ATF3 [T01313]; 8
PPAR-alpha:RXR-alpha [T05221]; 11
TFIID [T00820]; 7
HNF-3alpha [T02512]; 8
E2F [T00221]; 10
ER-alpha [T00261]; 5
ETF [T00270]; 11
c-Jun [T00133]; 7
NF-AT2 [T01945]; 10
NF-AT1 [T01948]; 10
STAT1beta [T01573]; 10
GATA-1 [T00306]; 6
MEF-2A [T01005]; 11
HOXD9 [T01424]; 10
HOXD10 [T01425]; 10
AP-1 [T00029]; 9
c-Fos [T00123]; 10
EBF [T05427]; 11
NF-kappaB [T00590]; 12
RelA [T00594]; 11
CREB [T00163]; 9
ATF-2 [T00167]; 10
ATF [T00051]; 12
NF-Y [T00150]; 8
CTF [T00174]; 12
HNF-4alpha [T03828]; 13
PU.1 [T02068]; 13
RAR-beta:RXR-alpha [T05420]; 12
Sp1 [T00759]; 10

Distribution of the nucleotides over the given chain:

A 25.0%
C 30.2%
G 27.5%
T 17.3%

Factors predicted by PROMO in IRF-5(transcript variant 2) sequence:

NAME; MATRIX_WIDTH;
XBP-1 [T00902]; 6
FOXP3 [T04280]; 6
PXR-1:RXR-alpha [T05671]; 8
TFII-I [T00824]; 6
YY1 [T00915]; 4
PEA3 [T00685]; 9
ENKTF-1 [T00255]; 8
RXR-alpha [T01345]; 7
MAZ [T00490]; 13
E2F-1 [T01542]; 8
Pax-5 [T00070]; 7
p53 [T00671]; 7
GR-alpha [T00337]; 5
PPAR-alpha:RXR-alpha [T05221]; 11
VDR [T00885]; 9
PR B [T00696]; 7
PR A [T01661]; 7
EBF [T05427]; 11
GR-beta [T01920]; 5
c-Jun [T00133]; 7
IRF-1 [T00423]; 9
NF-AT1 [T00550]; 9
HNF-3alpha [T02512]; 8
AP-2alphaA [T00035]; 6
NFI/CTF [T00094]; 8
GCF [T00320]; 9
RAR-beta:RXR-alpha [T05420]; 12
HNF-1A [T00368]; 8
STAT4 [T01577]; 6
c-Ets-1 [T00112]; 7
Elk-1 [T00250]; 9
ETF [T00270]; 11
Egr-3 [T00243]; 13
Ik-1 [T02702]; 13
C/EBPbeta [T00581]; 4
NF-1 [T00539]; 8
c-Ets-2 [T00113]; 9
Sp1 [T00759]; 10
NF-kappaB1 [T00593]; 11
RAR-beta [T00721]; 10
ER-alpha [T00261]; 5
T3R-beta1 [T00851]; 9
RelA [T00594]; 11
AR [T00040]; 9
COUP-TF1 [T00149]; 13
TFIID [T00820]; 7
GR [T05076]; 7
LEF-1 [T02905]; 8
GATA-1 [T00306]; 6
SRY [T00997]; 9
TCF-4E [T02878]; 7
C/EBPalpha [T00105]; 7
TCF-4 [T02918]; 10
GATA-3 [T00311]; 12
USF2 [T00878]; 10
AP-1 [T00029]; 9
c-Fos [T00123]; 10
ATF3 [T01313]; 8
PU.1 [T02068]; 13
WT1 [T00899]; 9
c-Myb [T00137]; 8
NF-Y [T00150]; 8
AhR:Arnt [T05394]; 10
NF-AT2 [T01945]; 10
STAT1beta [T01573]; 10
RAR-alpha1 [T00719]; 13

Distribution of the nucleotides over the given chain:

A 20.7%
C 34.2%
G 27.3%
T 17.8%

一月 21, 2011 - 發文作者 | 基礎醫學資訊相關

仍無迴響。

發表迴響

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / 變更 )

Twitter picture

You are commenting using your Twitter account. Log Out / 變更 )

Facebook照片

You are commenting using your Facebook account. Log Out / 變更 )

連結到 %s

Follow

Get every new post delivered to your Inbox.